HIV

Showing 1-10 of 16

This research service provides the latest trends in HIV molecular diagnostics and discusses the prospects of future developments in this segment.

USD 4,950.00

USD 3,712.50 save 25 %

This research service discusses technology developments in the HIV drugs sector.

USD 4,950.00

USD 3,712.50 save 25 %

18 Apr 2009  |  Europe

European HIV/AIDS Therapeutics Markets

 

This research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the ...

USD 4,950.00

USD 3,712.50 save 25 %

This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and challenges in the whole Europe. Together it recommends strategies for the players in these market...

USD 4,950.00

USD 3,712.50 save 25 %

07 Dec 2012  |  Europe

Analysis of European HIV Diagnostics Market

Increasing Adoption of HIV Nucleic Acid Testing (NAT) and Automation Spurs Market Growth.

The increase in HIV awareness among people has led to the demand for effective diagnostic products and solutions. As a result, some new products based on NAT technology and non-NAT technology platforms are being developed. This research service analyses the HIV diagnostics market in Europe, particularly, HIV NAT diagnostics and HIV Immunodiagnostic...

USD 4,950.00

USD 3,712.50 save 25 %

23 Jan 2013  |  North America

Analysis of the European HIV Drugs Market

Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This res...

USD 4,950.00

USD 3,712.50 save 25 %

05 Aug 1999  |  North America

United States HIV/AIDS Therapeutic Markets

 

 

USD 3,950.00

USD 2,962.50 save 25 %

15 Mar 2000  |  North America

United States HIV Diagnostic and Monitoring Markets

 

 

USD 3,950.00

USD 2,962.50 save 25 %

This research service analyzes the changing dynamics within the global HIV diagnostics and monitoring. Included in this research service are revenue forecasts, unit shipment, market and technology trends, major issues and challenges, analysis of growth opportunities, and competitive landscape. The market is segmented by - HIV Antibody Screening, ...

USD 3,950.00

USD 2,962.50 save 25 %

This research service analyzes the changing dynamics within the global HIV therapeutics market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, analysis of growth opportuniters, and individual product forecasts and...

USD 3,950.00

USD 2,962.50 save 25 %

Showing 1-10 of 16